Big Endothelin-1 vs Urotensin-II — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Big endothelin-1 (big ET-1) is a 38-amino acid peptide that is the direct precursor to the potent vasoconstrictor endothelin-1 (ET-1). It is produced by vascular endothelial cells from preproendothelin-1 and cleaved to the active 21-amino acid ET-1 by endothelin-converting enzyme...
Calculate Big Endothelin-1 dose →Human Urotensin-II (U-II) is an 11-amino acid cyclic peptide and the most potent mammalian vasoconstrictor identified to date - approximately 10 to 20 times more potent than endothelin-1 in isolated vascular preparations. Originally characterized in fish urophysis (caudal neurose...
Calculate Urotensin-II dose →| Parameter | Big Endothelin-1 | Urotensin-II |
|---|---|---|
| Category | Vasoactive Peptide | Vasoactive Peptide |
| Research | Preclinical/Biomarker | Active Research |
| Half-Life | Longer than ET-1 (~plasma half-life 3-5 min ET-1) | ~30 minutes (plasma) |
| Typical Dose | Research only | 0.01-1 nmol/kg/min IV (animal); picomolar concentrations produce vasoconstriction |
| Frequency | N/A | Acute infusion |
| Route | Endogenous; IV (research) | IV infusion (research/clinical studies) |
| FDA Status | No approval | Research compound; UT receptor antagonists in clinical trials |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.